Skip to content

I Have RP Posts

Second Sight Medical Products Inc. (EYES) Soars 7.41% on November 02

Source: Google News – Retinitis pigmentosa – Second Sight Medical Products Inc. (EYES) Soars 7.41% on November 02 Second Sight Medical Products Inc. (EYES) Soars 7.41% on November 02  Equities.com Full coverage Source: Google News – Retinitis pigmentosa – Second Sight Medical Products Inc. (EYES) Soars 7.41% on November…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B Gene

Source: ClinicalTrials.gov – Retinitis Pigmentosa – Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B Gene Condition:   Retinitis PigmentosaIntervention:   Biological: AAV2/5-hPDE6BSponsor:   Horama S.A.Recruiting Source: ClinicalTrials.gov – Retinitis Pigmentosa – Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa

Source: ClinicalTrials.gov – Retinitis Pigmentosa – Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa Condition:   Non-syndromic Retinitis PigmentosaIntervention:   Combination Product: Gene therapy: GS030-DP AND Medical device: GS030-MDSponsor:   GenSight BiologicsNot yet recruiting Source: ClinicalTrials.gov – Retinitis Pigmentosa – Dose-escalation Study to Evaluate…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest